Commit To Purchase Terns Pharmaceuticals At $6, Earn 60.8% Annualized Using Options

Investors eyeing a purchase of Terns Pharmaceuticals Inc (TERN) stock, but cautious about paying the going market price of $7.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2025 put at the $6 strike, which has a bid at the time of this writing of $1.65..